Mostrando 2 resultados de: 2
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: In vitro and in vivo characterization
ArticleAbstract: Background: Memantine, drug approved for moderate to severe Alzheimer's disease, has not shown to bePalabras claves:Alzheimer's disease, APPswe/PS1dE9 mice, astrocytes, BEnd.3, Brain targeting, Memantine, Nanoparticles, β-Amyloid plaquesAutores:Antoni Camins, Calpena A.C., Cano A., Carmona N., Egea M.A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Silva A.M., Souto E.M.B.Fuentes:scopusMemantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
ArticleAbstract: Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC)Palabras claves:drug delivery, glaucoma, Memantine, Nanoparticles, PLGA-PEGAutores:Antoni Camins, Calpena A.C., Cordeiro M.F., Davis B.M., Egea M.A., Espina M., Ettcheto M., García M.L., Guo L., Ravindran N., Sanchez-Lopez E., Silva A.M., Souto E.M.B.Fuentes:scopus